Clinical Trial Update: Determination and Validation of a Multi-analyte Assay for Lung Cancer Screening

View source ↗

Summary

Nucleix Ltd. is conducting a clinical trial to determine and validate a multi-analyte assay for lung cancer screening.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Nucleix Ltd. | Conditions: Lung Cancer | Status: ACTIVE_NOT_RECRUITING